2-Chloro-1H-benzo[d]imidazole-5-carbonitrile
CAS : 401567-00-8
Ref. 3D-FC165512
5g | Arrêté | ||
10g | Arrêté | ||
25g | Arrêté |
Informations sur le produit
- 1H-benzimidazole-5-carbonitrile, 2-chloro-
- 2-Chloro-1H-benzimidazole-5-carbonitrile
- 1H-Benzimidazole-6-carbonitrile,2-chloro-
2-Chloro-1H-benzo[d]imidazole-5-carbonitrile is a substance that has been used as an experimental treatment for Parkinson's disease. It is thought to act by blocking glutamate receptors, which are involved in the transmission of signals between neurons. 2-Chloro-1H-benzo[d]imidazole-5-carbonitrile has been shown to be orally active and has a pharmacokinetic profile that is suitable for administration once daily. The drug’s metabotropic properties have been demonstrated in animal models by antagonizing the effects of metabotropic glutamate receptor agonists such as LY354740.